Form 4 for JAZZ Jazz Pharmaceuticals plc
Accepted 2025-01-22 00:00:00 ET · period of report 2025-01-17 · accession 0001805688-25-000013 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-01-22 | 2025-01-17 | JAZZ | Iannone Robert | EVP, CMO, G R, D | F - Tax | $122.62 | -2,181 | 67.8K | -3% | -$267.4K | |
| 2025-01-22 | 2025-01-17 | JAZZ | Iannone Robert | EVP, CMO, G R, D | A - Grant | $0.00 | +7,506 | 69.9K | +12% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2025-01-17 | F | D | 2,181 | $122.62 | 67,766 | D | — | — | |
| 2 | Common | Ordinary Shares | 2025-01-17 | A | A | 7,506 | $0.00 | 69,947 | D | — | — | (F2) The Reporting Person acquired 167 ordinary shares on May 31, 2024 and 48 ordinary shares on November 29, 2024 under a Section 423 Employee Stock Purchase Plan. |